001790.KS
TS Corporation [001790.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
001790.KS Stock Summary
Top 001790.KS Correlated Resources
001790.KS
Top 10 Correlated ETFs
001790.KS
Top 10 Correlated Stocks
001790.KS
001790.KS Financial details
Company Rating
Buy
Market Cap
246.22B
Income
21.12B
Revenue
1368.25B
Book val./share
6331.47
Cash/share
-
Dividend
110
Dividend %
4.01%
Employees
281
Optionable
No
Shortable
Yes
Earnings
-
P/E
10.89
Forward P/E
-
PEG
-27.65
P/S
0.17
P/B
0.43
P/C
-
P/FCF
-3.61
Quick Ratio
-
Current Ratio
1.52
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
252.16
EPS next Y
-
EPS next Q
-
EPS this Y
-8.97%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
14.2%
Revenue last 5Y
-0.21%
Revenue Q/Q
3.07%
EPS Q/Q
103.83%
-
-
-
-
SMA20
7.9%
SMA50
-11.65%
SMA100
-16.96%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
4%
ROC
0.04%
Gross Margin
9%
Oper. Margin
3%
Profit Margin
2%
Payout
44%
Shs Outstand
89.7M
Shs Float
33.97M
-
-
-
-
Target Price
-
52W Range
2375.0-6270.0
52W High
-56.22%
52W Low
+15.58%
RSI
57.89
Rel Volume
0.36
Avg Volume
591.59K
Volume
210.07K
Perf Week
4.97%
Perf Month
13.43%
Perf Quarter
-32.22%
Perf Half Y
-39.6%
-
-
-
-
Beta
0.856751
-
-
Volatility
26.84%, 102.6%
Prev Close
-0.36%
Price
2745
Change
0.18%
001790.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 15.43K | 14.65K | 14.57K | 14.39K | 14.94K | |
| Net income per share | 128.44 | 117.82 | 178.31 | 267.84 | 238.95 | |
| Operating cash flow per share | 127.6 | 152.75 | 102.95 | 767.09 | -140.24 | |
| Free cash flow per share | -41.57 | 34.19 | -2.4 | 613.62 | -265.59 | |
| Cash per share | 2.17K | 1.93K | 1.93K | 2.33K | 2.02K | |
| Book value per share | 5.47K | 5.47K | 5.62K | 5.67K | 6.05K | |
| Tangible book value per share | 5.44K | 5.45K | 5.61K | 5.66K | 6.05K | |
| Share holders equity per share | 5.47K | 5.47K | 5.62K | 5.67K | 6.05K | |
| Interest debt per share | 5.61K | 5.44K | 5.44K | 5.14K | 5.15K | |
| Market cap | 200.66B | 165.98B | 159.12B | 168B | 230.05B | |
| Enterprise value | 541.66B | 520.25B | 494.74B | 491.44B | 544.51B | |
| P/E ratio | 18.92 | 17.06 | 10.8 | 7.43 | 11.4 | |
| Price to sales ratio | 0.16 | 0.14 | 0.13 | 0.14 | 0.18 | |
| POCF ratio | 19.04 | 13.16 | 18.7 | 2.59 | -19.43 | |
| PFCF ratio | -58.45 | 58.78 | -802.73 | 3.24 | -10.26 | |
| P/B Ratio | 0.44 | 0.37 | 0.34 | 0.35 | 0.45 | |
| PTB ratio | 0.44 | 0.37 | 0.34 | 0.35 | 0.45 | |
| EV to sales | 0.42 | 0.43 | 0.41 | 0.4 | 0.43 | |
| Enterprise value over EBITDA | 12.85 | 11.78 | 9.61 | 7.86 | 10.79 | |
| EV to operating cash flow | 51.41 | 41.24 | 58.14 | 7.59 | -45.99 | |
| EV to free cash flow | -157.77 | 184.26 | -2.5K | 9.49 | -24.29 | |
| Earnings yield | 0.05 | 0.06 | 0.09 | 0.13 | 0.09 | |
| Free cash flow yield | -0.02 | 0.02 | 0 | 0.31 | -0.1 | |
| Debt to equity | 0.46 | 0.49 | 0.45 | 0.44 | 0.35 | |
| Debt to assets | 0.61 | 0.6 | 0.59 | 0.58 | 0.57 | |
| Net debt to EBITDA | 8.09 | 8.02 | 6.52 | 5.17 | 6.23 | |
| Current ratio | 1.29 | 1.3 | 1.29 | 1.36 | 1.35 | |
| Interest coverage | 1.26 | 2.07 | 2.15 | 3.98 | 4.74 | |
| Income quality | 0.99 | 1.3 | 0.58 | 2.86 | -0.59 | |
| Dividend Yield | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | |
| Payout ratio | 0.53 | 0.51 | 0.34 | 0.27 | 0.4 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -1.33 | -0.78 | -1.02 | -0.2 | 0.89 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Capex to depreciation | -0.92 | -0.64 | -0.52 | -0.83 | -0.74 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.97K | 3.81K | 4.75K | 5.84K | 5.7K | |
| ROIC | 0.02 | 0.04 | 0.04 | 0.06 | 0.06 | |
| Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Graham Net | -5.1K | -5.16K | -4.98K | -4.43K | -4.6K | |
| Working capital | 115.04B | 117.14B | 118.19B | 141.72B | 149.14B | |
| Tangible asset value | 449.36B | 449.67B | 463.62B | 477.9B | 510.56B | |
| Net current asset value | -184.49B | -176.93B | -156.39B | -134.63B | -98.61B | |
| Invested capital | 1 | 0.96 | 0.94 | 0.88 | 0.83 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 47.41B | 49.01B | 48.02B | 48.28B | 48.87B | |
| Average inventory | 196.57B | 195.14B | 204.42B | 192.96B | 208.4B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 14.83 | 16.9 | 16.24 | 16.54 | 16.04 | |
| Days of inventory on hand | 63.76 | 67.07 | 73.39 | 66.1 | 72.59 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 24.62 | 21.59 | 22.48 | 22.07 | 22.76 | |
| Inventory turnover | 5.72 | 5.44 | 4.97 | 5.52 | 5.03 | |
| ROE | 0.02 | 0.02 | 0.03 | 0.05 | 0.04 | |
| Capex per share | -169.18 | -118.56 | -105.34 | -153.46 | -125.35 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 3.95K | 4.08K | 3.8K | 4.16K | 4.29K | |
| Net income per share | 82.1 | -1.89 | -44.17 | 98.15 | 200.07 | |
| Operating cash flow per share | -155.65 | -277.7 | -172.27 | -160.21 | -50.74 | |
| Free cash flow per share | -185.32 | -307.11 | -194.11 | -182.86 | -75.47 | |
| Cash per share | 0 | 2.04K | 0 | 0 | 0 | |
| Book value per share | 6.08K | 6.1K | 5.95K | 6.12K | 6.33K | |
| Tangible book value per share | 6.08K | 6.09K | 5.95K | 6.12K | 6.33K | |
| Share holders equity per share | 6.08K | 6.1K | 5.95K | 6.12K | 6.33K | |
| Interest debt per share | 0 | 5.11K | 13.79 | 76.28 | 206.04 | |
| Market cap | 273.09B | 252.99B | 242.1B | 278.12B | 216.55B | |
| Enterprise value | 273.09B | 567.46B | 242.1B | 278.12B | 216.55B | |
| P/E ratio | 9.93 | -399.94 | -16.36 | 8.46 | 3.23 | |
| Price to sales ratio | 0.82 | 0.74 | 0.76 | 0.8 | 0.6 | |
| POCF ratio | -20.94 | -10.87 | -16.78 | -20.72 | -50.94 | |
| PFCF ratio | -17.59 | -9.83 | -14.89 | -18.16 | -34.25 | |
| P/B Ratio | 0.54 | 0.5 | 0.49 | 0.54 | 0.41 | |
| PTB ratio | 0.54 | 0.5 | 0.49 | 0.54 | 0.41 | |
| EV to sales | 0.82 | 1.66 | 0.76 | 0.8 | 0.6 | |
| Enterprise value over EBITDA | 22.24 | 92.77 | 127.29 | 15.81 | 5.44 | |
| EV to operating cash flow | -20.94 | -24.39 | -16.78 | -20.72 | -50.94 | |
| EV to free cash flow | -17.59 | -22.06 | -14.89 | -18.16 | -34.25 | |
| Earnings yield | 0.03 | 0 | -0.02 | 0.03 | 0.08 | |
| Free cash flow yield | -0.06 | -0.1 | -0.07 | -0.06 | -0.03 | |
| Debt to equity | 0 | 0.35 | 0 | 0 | 0 | |
| Debt to assets | 0.57 | 0.57 | 0.59 | 0.6 | 0.58 | |
| Net debt to EBITDA | 0 | 51.41 | 0 | 0 | 0 | |
| Current ratio | 1.3 | 1.35 | 1.47 | 1.59 | 1.52 | |
| Interest coverage | 0 | 1.45 | 0.6 | 2.42 | 0.91 | |
| Income quality | -1.9 | 147.1 | 3.9 | -1.63 | -0.25 | |
| Dividend Yield | 0 | 0 | 0.04 | 0 | 0 | |
| Payout ratio | 0 | 0 | -2.67 | 0.09 | 0 | |
| Sales general and administrative to revenue | 0.07 | 0 | 0.07 | 0.07 | 0.06 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.19 | 0.11 | 0.13 | 0.14 | 0.49 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Capex to depreciation | -0.7 | -0.7 | -0.53 | -0.57 | -0.62 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.35K | 509 | 2.43K | 3.68K | 5.34K | |
| ROIC | 0.05 | 0 | 0 | 0.02 | 0.02 | |
| Return on tangible assets | 0.01 | 0 | 0 | 0.01 | 0.01 | |
| Graham Net | -8.22K | -4.64K | -8.65K | -9.1K | -8.81K | |
| Working capital | 133.76B | 149.14B | 198.29B | 251.9B | 229.63B | |
| Tangible asset value | 0 | 510.56B | 0 | 0 | 0 | |
| Net current asset value | -107.67B | -98.61B | -106.91B | -84.91B | -65.36B | |
| Invested capital | 0 | 0.83 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 14.11 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 63.88 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 6.38 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 1.41 | 0 | 0 | 0 | |
| ROE | 0.01 | 0 | -0.01 | 0.02 | 0.03 | |
| Capex per share | -29.66 | -29.41 | -21.83 | -22.65 | -24.73 |
001790.KS Frequently Asked Questions
What is TS Corporation stock symbol ?
TS Corporation is a US stock and trading under the symbol 001790.KS
What is TS Corporation stock quote today ?
TS Corporation stock price is $2745 today.
Is TS Corporation stock public?
Yes, TS Corporation is a publicly traded company.
Company Profile
- Volume Average 591.59K
- Market Capitalization 246.22B
- Employee 281
- Headquarters Seoul,US
- IPO Date 2000-01-04
-
Website
https://www.ts.co.kr 
TS Corporation operates as a food company in South Korea. The company produces and supplies sugar and food stuff, food materials, additives, dairy products, and raw materials for bakery, mixed seasonings, and other agricultural products, as well as trades in non-ferrous metals. It also provides animal feed, including livestock feed under the Rainbow name; administrative support services, such as digital solutions for farm management; and pathology lab services comprising testing, analysis, and examination services to farmers. In addition, the company develops various nutraceuticals and premium foods to control aging and prevent adult diseases; and develops, produces, and markets two biological products, which include erythropoietin and streptokinase. It also exports its products to China, Southeast Asia, Micronesia, and internationally. The company was founded in 1956 and is headquartered in Seoul, South Korea.
